Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEF.L Regulatory News (APEF)

  • There is currently no data for APEF

Interim Management Statement

13 Aug 2013 15:16

RNS Number : 6126L
Aberdeen Private Equity Fund Ltd
13 August 2013
 



13 August 2013

Aberdeen Private Equity Fund Limited

Unaudited Interim Management Statement - 3 months to 30 June 2013

To the shareholders of Aberdeen Private Equity Fund Limited

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 April to 30 June 2013, and contains information that covers this period and up to the publication date for this interim management statement, unless otherwise specified.

Overview

Aberdeen Private Equity Fund Limited ("the Company") is a Guernsey closed-ended investment company listed on the London Stock Exchange. The principal investment focus of the Company is to invest in private equity and private equity-like funds.

Investment Objective and Policy

The investment objective of the Company is to generate long-term capital gains, through investment in a diversified portfolio of private equity funds. The Company may also hold direct holdings as an ancillary part of its portfolio, in hedge funds, other speciality funds, unquoted companies and unquoted securities, including fixed-interest securities, cash-equivalent investments and cash.

Material Events

With effect from June 2013, the investment management agreement for the Company was transferred by way of novation to Aberdeen SVG Private Equity Managers Limited. Aberdeen SVG is a strategic alliance between Aberdeen Asset Management and private equity investor SVG Capital, with assets under management or advice of €6bn (as at 31 March 2013). The business brings together SVG Advisers' and Aberdeen's private equity teams' experience and employs over 40 professionals in one global team, across a broad range of complementary disciplines, offering on-the-ground access to major private equity markets. There will be no change in the day to day management of the Company as a result of this change.

On 4 July 2013, the Company's Annual Financial Report announcement was released.

Portfolio News

The Company's commitments total $266.0million of which approximately $191.1million has been drawn down. There were twenty one capital calls made in the quarter with an aggregate amount of $3.2million. The Company has received gross distributions, including return of excess capital called, of $118.9million since inception. The Company received $11.9million in distributions in the quarter. Nineteen revaluations were received during the quarter, ten were upwards revaluations and nine were downwards revaluations. Of the investments, 85% are calculated using currently available 31-Mar valuations, while the remaining 15% of investments are calculated using the last available valuations which are dated between 31-Mar and 30-June.

Portfolio Holdings as at 30 June 2013

%

Thomas H Lee Parallel Fund VI LP

7.3

Thoma Bravo IX Fund LP

5.7

Greenpark International Investors III LP

5.4

Northzone VI LP

5.4

Tenaya Capital V LP

5.2

Coller International Partners V LP

5.1

Silver Lake Partners III LP

4.9

DFJ Athena LP

4.9

RHO Ventures VI LP

4.7

Lion Capital Fund III LP

4.1

Pine Brook Capital Partners LP

3.9

MatlinPatterson Global Opportunities Partners III LP

3.7

Longreach Capital Partners Ireland 1, L.P.

3.5

Goldman Sachs Capital Partners VI LP

3.3

HIG Bayside Debt & LBO Fund II LP

3.2

Resonant Music LP

2.7

Gores Capital Partners III LP

2.6

Oaktree OCM Opportunities Fund VIIb LP

2.4

e2v Technologies

1.2

Tenaya Capital VI LP

0.7

Pangaea Two Parallel L.P.

0.6

Pinebridge Latin America Partners II LP

0.5

SVG Strategic Recovery Fund II LP

0.3

Journey Group

0.2

Lavendon Group

0.2

Longreach Capital Partners 2 - USD, L.P.

-

Co-Investments

0.6

Cash

17.7

 

Total Investments

 

100.0

 

Total Number of Investments

 

27

 

Cash: The Company currently invests its cash with counterparties that appear on Aberdeen Asset Managers Limited's approved lending list.

 

Geographical Allocation as of 30 June 2013

%

Global

40.8

North America

35.7

Europe

12.6

Asia & Other

10.9

 

Total

 

100.0

 

General Description of Company's Financial Position as at 30 June 2013

Sterling Share NAV: 110.59 pence

Market Capitalisation: £93.3 million

As described in the Company's prospectus, and as has been the case since its launch, the net asset value ("NAV") and the NAV per share are both calculated monthly by the Company's administrator based on the latest published NAV for each underlying fund.

Investments in underlying funds for the month ended 30 June 2013 are valued using the values (whether final or estimated) as advised by their managers, general partners or administrators. The Company therefore relied on valuation and reporting methods used by the managers, general partners or administrators of the underlying funds in deriving the 30 June 2013 NAV and NAV per share. It is possible, from time to time, that if there is good cause to reduce the valuation, the manager will do so accordingly.

Benchmark

The Company does not currently have a benchmark. Due to the nature of the Company's investments, there are no meaningful indices against which to compare the performance of the Company.

Performance (%) (GBP)

Cumulative Performance

 

As at

30/06/2013

1 month

3 months

6 months

1 year

3 years

5 years

Share Price

85.5p

1.8

(3.9)

23.0

50.0

71.9

2.8

NAV

110.6p

(0.5)

(1.4)

8.0

6.9

26.4

11.5

 

Discrete Performance

 

Year Ended:

30/06/13

30/06/12

30/06/11

30/06/10

30/06/09

Share Price

50.0

(14.5)

34.1

0.0

(40.2)

NAVA

6.9

9.1

8.4

12.5

(21.6)

 

Total Return; NAV to NAV, Net Income Reinvested, GBP. Share price total return is on a mid-to-mid basis.

Source: Aberdeen Asset Managers Limited, Lipper and Morningstar.

A Including current year revenue.

Dividend calculations are to reinvest as at the ex-dividend date. NAV returns based on NAVs with debt valued at fair value.

Past performance is not a guide to future results.

The Board is not aware of any other significant events or transactions which have occurred between 1 July 2013 and the publication date of this interim management statement which would have a material impact on the financial position of the Company.

For latest performance information, please refer to the Company's factsheet at:

http://www.aberdeenprivateequity.co.uk/doc.nsf/Lit/FactsheetUKClosedAberdeenPrivateEquityFund*

* Neither the content of the Company's website nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested.

 

For Aberdeen Private Equity Fund Limited

Ipes (Guernsey) Limited

Company Secretary

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAGRUPWGCW
Date   Source Headline
27th Jul 201612:48 pmRNSPosting of Annual Financial Report and AGM Notice
12th Jul 20167:00 amRNSAnnual Financial Report
11th Jul 20165:45 pmRNSPortfolio Listing, May 2016
8th Jul 20164:59 pmRNSNet Asset Value(s)
7th Jun 201612:55 pmRNSPortfolio Listing, April 2016
6th Jun 20161:27 pmRNSNet Asset Value, April 2016
3rd May 201611:02 amRNSTR-1: Notification of Major Interest in Shares
26th Apr 20165:10 pmRNSPortfolio Listing, March 2016
22nd Apr 20163:18 pmRNSNet Asset Value, March 2016
14th Apr 201610:53 amRNSCompliance with Model Code
4th Apr 20167:00 amRNSBank Facility
1st Apr 20164:50 pmRNSDirector/PDMR Shareholding
31st Mar 20169:09 amRNSPortfolio Listing, February 2016
24th Mar 20164:40 pmRNSNet Asset Value, February 2016
25th Feb 20163:49 pmRNSPortfolio Listing, January 2016
24th Feb 20169:10 amRNSNet Asset Value, January 2016
19th Feb 20164:31 pmRNSHome Member State
26th Jan 20164:11 pmRNSPortfolio Listing, December 2015
26th Jan 20169:57 amRNSNet Asset Value, December 2015
22nd Dec 20154:34 pmRNSPortfolio Listing, November 2015
22nd Dec 20158:35 amRNSNet Asset Value, November 2015
8th Dec 201510:11 amRNSPosting of Half Yearly Report
30th Nov 20155:06 pmRNSTR-1: Notification of Major Interest in Shares
26th Nov 20157:00 amRNSHalf Yearly Report
23rd Nov 20154:34 pmRNSPortfolio listing, October 2015
23rd Nov 20152:34 pmRNSNet Asset Value, October 2015
16th Nov 201512:42 pmRNSEdison issues review: Aberdeen Private Equity Fund
12th Nov 20157:51 amRNSTR-1: Notification of Major Interest in Shares
10th Nov 20155:19 pmRNSHolding(s) in Company
30th Oct 20153:54 pmRNSAppointment of New AIFM
27th Oct 20151:55 pmRNSPortfolio listing, September 2015
26th Oct 20153:57 pmRNSNet Asset Value, September 2015
1st Oct 20157:00 amRNSCompliance with Model Code
24th Sep 20159:43 amRNSNet Asset Value, August 2015
22nd Sep 20155:16 pmRNSDirector/PDMR Shareholding
15th Sep 20156:10 pmRNSResult of AGM
27th Aug 20153:21 pmRNSPortfolio listing, July 2015
27th Aug 20157:01 amRNSNet Asset Value, July 2015
28th Jul 20152:46 pmRNSPortfolio listing, June 2015
28th Jul 20158:15 amRNSNet Asset Value, June 2015
16th Jul 20152:21 pmRNSPosting of Annual Report and AGM Notice
1st Jul 20157:00 amRNSAnnual Financial Report
29th Jun 20155:09 pmRNSPortfolio listing, May 2015
25th Jun 201511:45 amRNSNet Asset Value, May 2015
27th May 201511:26 amRNSPortfolio Listing, April 2015
26th May 20154:08 pmRNSNet Asset Value, April 2015
27th Apr 20154:02 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20152:55 pmRNSPortfolio Listing, March 2015
24th Apr 20154:11 pmRNSNet Asset Value, March 2015
9th Apr 20153:59 pmRNSCompliance with Model Code

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.